From a practical standpoint, our observations suggest several clinical scenarios in which genetic evaluation for SAMHD1 deficiency should be considered in children with seemingly common autoimmune diseases such as juvenile dermatomyositis or systemic lupus erythematosus. This evidence concerns the gene SAMHD1 and juvenile dermatomyositis.